History

1982

Grażyna Szwarczyńska, MPharm,
launches production of pharmaceutical
preparations and cosmetics

1988

Biofarm
established as 100%
Polish-owned
partnership

1990

Opening of Biofarm's
drug warehouse

1991

Theospirex retard 300 mg
first drug in production

1995

Wałbrzyska 13 production, laboratories & offices moved to the current location

1996

Ginkofar
our first in-house
development

1998

10th anniversary
119 employees
10 representatives

2001

EU GMP Certificate
(one of the first Polish companies
to achieve this standard)

2002

Biofarm commences export sales

2007

Atrox
- first Polish atrovastatin

2009

Patented Rosuvastatin
formulation - a method preparation
of a pharmaceutical compostition
containing rosuhstatin

2012

Biomentin
first memantine
generic in Europe

2013

We sponsor
Biofarm Basket Poznań team

2016

Biofarm's production so far
22,5 mln packages
700 mln tablets
45 mln capsules

2016

Biofarm becomes a 100% family-owned company

2018

2018

Proaxon
first Polish oseltamivir
in the form of a small tablet

2018

Tamivil
launch of the patented Oseltamivir
formulation in the form of a small tablet

2019

Biotynox Forte
the first drug in Poland with the highest dose of biotin 10 mg

2019

Solicidiol highest
calcifediol dose on
the Polish market

2019

180 products registered in Poland, around 80% developed in-house

2020

During the COVID - 19 pandemic, Biofarm supports pharmacists and doctors by providing disinfectants and personal care products, as well as drug and equipment donations

2020

Launch of Vigalex, Biofarm becomes a Vitamin D3 expert

2020

Launching cooperation with sports clubs across Poland. The company supports healthy competition among children and youth

2022

Rosuvastatin launched in 17 countries

2023

Biofarm's products present on four continents, in 30 countries

2023

35 years of Biofarm's presence on the market